Home
/
Dolby Laboratories, Inc.
/
Financials
/
Quarterly
Dolby Laboratories, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Dolby Laboratories, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 26, 2025
$346.71M
Jan 29, 2026
Q3
2025
Jun 27, 2025
$315.55M
Jul 31, 2025
Q2
2025
Mar 28, 2025
$369.56M
May 1, 2025
Q1
2026
Dec 27, 2024
$357.00M
Jan 29, 2026
Q3
2025
Jun 28, 2024
$288.82M
Jul 31, 2025
Q2
2025
Mar 29, 2024
$364.52M
May 1, 2025
Q1
2025
Dec 29, 2023
$315.57M
Jan 30, 2025
Q3
2024
Jun 30, 2023
$298.37M
Aug 7, 2024
Q2
2024
Mar 31, 2023
$375.89M
May 2, 2024
Q1
2024
Dec 30, 2022
$334.92M
Feb 2, 2024
Q3
2023
Jul 1, 2022
$289.59M
Aug 3, 2023
Q2
2023
Apr 1, 2022
$334.37M
May 5, 2023
Q1
2023
Dec 31, 2021
$351.63M
Feb 2, 2023
Q3
2022
Jun 25, 2021
$286.80M
Aug 9, 2022
Q2
2022
Mar 26, 2021
$319.56M
May 5, 2022
Q1
2022
Dec 25, 2020
$389.87M
Feb 4, 2022
Q3
2021
Jun 26, 2020
$246.91M
Jul 29, 2021
Q2
2021
Mar 27, 2020
$351.82M
May 4, 2021
Q1
2021
Dec 27, 2019
$291.88M
Jan 29, 2021
Q3
2020
Jun 28, 2019
$302.16M
Aug 3, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 26, 2025
$346.71M
Jan 29, 2026
Q3
2025
Jun 27, 2025
$315.55M
Jul 31, 2025
Q2
2025
Mar 28, 2025
$369.56M
May 1, 2025
Q1
2026
Dec 27, 2024
$357.00M
Jan 29, 2026
Q3
2025
Jun 28, 2024
$288.82M
Jul 31, 2025
Q2
2025
Mar 29, 2024
$364.52M
May 1, 2025
Q1
2025
Dec 29, 2023
$315.57M
Jan 30, 2025
Q3
2024
Jun 30, 2023
$298.37M
Aug 7, 2024
Q2
2024
Mar 31, 2023
$375.89M
May 2, 2024
Q1
2024
Dec 30, 2022
$334.92M
Feb 2, 2024
Q3
2023
Jul 1, 2022
$289.59M
Aug 3, 2023
Q2
2023
Apr 1, 2022
$334.37M
May 5, 2023
Q1
2023
Dec 31, 2021
$351.63M
Feb 2, 2023
Q3
2022
Jun 25, 2021
$286.80M
Aug 9, 2022
Q2
2022
Mar 26, 2021
$319.56M
May 5, 2022
Q1
2022
Dec 25, 2020
$389.87M
Feb 4, 2022
Q3
2021
Jun 26, 2020
$246.91M
Jul 29, 2021
Q2
2021
Mar 27, 2020
$351.82M
May 4, 2021
Q1
2021
Dec 27, 2019
$291.88M
Jan 29, 2021
Q3
2020
Jun 28, 2019
$302.16M
Aug 3, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 26, 2025
$53.33M
Jan 29, 2026
Q3
2025
Jun 27, 2025
$46.07M
Jul 31, 2025
Q2
2025
Mar 28, 2025
$91.79M
May 1, 2025
Q1
2026
Dec 27, 2024
$67.82M
Jan 29, 2026
Q3
2025
Jun 28, 2024
$38.44M
Jul 31, 2025
Q2
2025
Mar 29, 2024
$97.83M
May 1, 2025
Q1
2025
Dec 29, 2023
$66.98M
Jan 30, 2025
Q3
2024
Jun 30, 2023
$16.40M
Aug 7, 2024
Q2
2024
Mar 31, 2023
$95.70M
May 2, 2024
Q1
2024
Dec 30, 2022
$79.38M
Feb 2, 2024
Q3
2023
Jul 1, 2022
$39.60M
Aug 3, 2023
Q2
2023
Apr 1, 2022
$36.72M
May 5, 2023
Q1
2023
Dec 31, 2021
$80.01M
Feb 2, 2023
Q3
2022
Jun 25, 2021
$54.62M
Aug 9, 2022
Q2
2022
Mar 26, 2021
$76.22M
May 5, 2022
Q1
2022
Dec 25, 2020
$135.20M
Feb 4, 2022
Q3
2021
Jun 26, 2020
$67.29M
Jul 29, 2021
Q2
2021
Mar 27, 2020
$88.50M
May 4, 2021
Q1
2021
Dec 27, 2019
$48.75M
Jan 29, 2021
Q3
2020
Jun 28, 2019
$39.57M
Aug 3, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2026
Dec 26, 2025
$62.16M
Jan 29, 2026
Q3
2025
Jun 27, 2025
$47.64M
Jul 31, 2025
Q2
2025
Mar 28, 2025
$107.76M
May 1, 2025
Q1
2026
Dec 27, 2024
$79.88M
Jan 29, 2026
Q3
2025
Jun 28, 2024
$36.78M
Jul 31, 2025
Q2
2025
Mar 29, 2024
$108.97M
May 1, 2025
Q1
2025
Dec 29, 2023
$66.22M
Jan 30, 2025
Q3
2024
Jun 30, 2023
$15.94M
Aug 7, 2024
Q2
2024
Mar 31, 2023
$109.22M
May 2, 2024
Q1
2024
Dec 30, 2022
$94.09M
Feb 2, 2024
Q3
2023
Jul 1, 2022
$45.57M
Aug 3, 2023
Q2
2023
Apr 1, 2022
$43.35M
May 5, 2023
Q1
2023
Dec 31, 2021
$90.58M
Feb 2, 2023
Q3
2022
Jun 25, 2021
$56.09M
Aug 9, 2022
Q2
2022
Mar 26, 2021
$83.19M
May 5, 2022
Q1
2022
Dec 25, 2020
$164.75M
Feb 4, 2022
Q3
2021
Jun 26, 2020
$34.14M
Jul 29, 2021
Q2
2021
Mar 27, 2020
$105.95M
May 4, 2021
Q1
2021
Dec 27, 2019
$48.59M
Jan 29, 2021
Q3
2020
Jun 28, 2019
$34.26M
Aug 3, 2020